TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Precipio, Inc.
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Precipio conducted a comprehensive study with Memorial Sloan Kettering Cancer Center, evaluating their BCR::ABL1 assay using 895 patient samples. The study demonstrated superior performance and positive impacts on patient care and laboratory workflows.

Insights
PRPO   positive

Company presented a successful joint research study demonstrating improved diagnostic capabilities and potential positive patient outcomes